Expert of Fuda Cancer Hospital Being Invited as Guest at Russian Conference on Cancer Treatment

                  Dr Mu Feng (L1) was invited asguest at the conference.

From October 7 to 8 in 2016, the Second Russian Seminar on Cancer Treatment and New Technology was held at Russian State Surgery Research Institute solemnly. Experts and scholars for China, Sweden, Britain, Austria, Italy, Hungary, etc. gathered at Moscow to attend this event.

This event was held by Russian State Surgery Research Institute. Vice president of Guangzhou Fuda Cancer Hospital Dr Mu Feng was invited to be a guest and deliver a speech on “Experience of 8000 Cases Cryosurgery for Cancer”.

Dr Mu Feng delivered a special report on “Experience of 8000 Cases Cryosurgery for Cancer” at the seminar. 

The experts had an in-depth and heated discussion on related topics about cryosurgery in the seminar. Italian expert C. Pusceddu and Russian experts introduced their research and experience in the field of cryosurgery for renal cancer, soft tissue sarcoma, etc. And Russian expert showed needle-type cryoprobe with liquid nitrogen that they recently invented.

Foreign experts quoted experience and pictures of FUDA in their reports many times.

Dr Mu Feng and president of Russian Society of Cryosurgery Alexander Zhao (Left)

Experts attending the event had a discussion.

Vice president Mu Feng pointed out that resection, chemotherapy and radiation therapy consisted of conventional treatments. With the development of imaging technique, prevailing intervention oncology is a great progress in fighting cancer. Interventional therapy has become the fourth main treatment besides surgery, chemotherapy and radiation therapy. For example, like modern cryosurgery that represented the freezing technique with argon and helium emerging in the late period of last century, it brought hope to the cancer patients who couldn’t have surgery.    

As a treatment, cryosurgery has been approved and applied in clinical cancer treatment widely in the world. Clinical research showed that cryosurgery has irreplaceable function compared with other treatments. Especially it could perform percutaneous treatment which guided by imaging. And it security to great vessel also makes it have extensive application. 

Cryosurgery not only brings benefit to terminal patients who couldn’t accept surgery, in treating early stage cancer, it also achieves the same effect of surgery, like liver cancer, renal cancer, prostate cancer and lung cancer. As for unresectable tumor, like surgery, cryosurgery can eliminate most of it.

Cryosurgery technique of China has a leading position in the world. There are about 20 thousand cases of cryosurgery in our country. Just a Guangzhou Fuda Cancer Hospital, the number of the cryosurgery cases for cancer is more than 10 thousand person-times, which ranking the first place in the world. So they accumulate abundant experience of cryosurgery for cancer.

Fuda Cancer Hospital firstly applied cryosurgery in central lung cancer, local progressive pancreatic cancer and giant liver cancer. It has been a world-renowned characteristic and attracted patients from five continents of the world. In treating pancreatic cancer, FUDA leads the world. In American medical retrieval system, one third of literatures of cryosurgery for pancreatic cancer are from Guangzhou Fuda Cancer Hospital.

As one of the units firstly introduced cryosurgery technique in China, Fuda Cancer Hospital successively received Special Contribution Award in International Cryosurgery by International Society of Cryosurgery, Excellent Contribution Award at International Conference on Interventional Oncology, Excellent Contribution Award at Symposium on Mini-invasively Cancer Treatment of China, etc.

It’s said that the Third Asian Conference on Cryosurgery would be held at Beijing on November 4. Experts of Fuda Cancer Hospital will introduce their research outcome and clinical experience at the conference.